| Powerful cocaine-like actions of 3, 4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products MH Baumann, JS Partilla, KR Lehner, EB Thorndike, AF Hoffman, M Holy, ... Neuropsychopharmacology 38 (4), 552-562, 2013 | 496 | 2013 |
| Amphetamines, new psychoactive drugs and the monoamine transporter cycle HH Sitte, M Freissmuth Trends in pharmacological sciences 36 (1), 41-50, 2015 | 294 | 2015 |
| Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport JU Fog, H Khoshbouei, M Holy, WA Owens, CB Vaegter, N Sen, ... Neuron 51 (4), 417-429, 2006 | 286 | 2006 |
| Carrier‐mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter HH Sitte, S Huck, H Reither, S Boehm, EA Singer, C Pifl Journal of neurochemistry 71 (3), 1289-1297, 1998 | 244 | 1998 |
| Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells JA Schmid, P Scholze, O Kudlacek, M Freissmuth, EA Singer, HH Sitte Journal of Biological Chemistry 276 (6), 3805-3810, 2001 | 238 | 2001 |
| Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation AH Rajput, HH Sitte, A Rajput, ME Fenton, C Pifl, O Hornykiewicz Neurology 70 (16_part_2), 1403-1410, 2008 | 207 | 2008 |
| Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation AM Weihs, C Fuchs, AH Teuschl, J Hartinger, P Slezak, R Mittermayr, ... Journal of Biological Chemistry 289 (39), 27090-27104, 2014 | 188 | 2014 |
| Actovegin®: a biological drug for more than 5 decades. F Buchmayer, J Pleiner, MW Elmlinger, G Lauer, G Nell, HH Sitte Wiener Medizinische Wochenschrift (1946) 161 (3-4), 80-88, 2011 | 183 | 2011 |
| Anomalous dopamine release associated with a human dopamine transporter coding variant MS Mazei-Robison, E Bowton, M Holy, M Schmudermaier, M Freissmuth, ... Journal of Neuroscience 28 (28), 7040-7046, 2008 | 166 | 2008 |
| Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3 LA Egaña, RA Cuevas, TB Baust, LA Parra, RK Leak, S Hochendoner, ... Journal of Neuroscience 29 (14), 4592-4604, 2009 | 163 | 2009 |
| Missense dopamine transporter mutations associate with adult parkinsonism and ADHD FH Hansen, T Skjørringe, S Yasmeen, NV Arends, MA Sahai, K Erreger, ... The Journal of clinical investigation 124 (7), 3107-3120, 2014 | 162 | 2014 |
| The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine T Steinkellner, M Freissmuth, HH Sitte, T Montgomery Walter de Gruyter 392 (1-2), 103-115, 2011 | 157 | 2011 |
| The N terminus of monoamine transporters is a lever required for the action of amphetamines S Sucic, S Dallinger, B Zdrazil, R Weissensteiner, TN Jørgensen, M Holy, ... Journal of Biological Chemistry 285 (14), 10924-10938, 2010 | 156 | 2010 |
| Reduced default mode network suppression during a working memory task in remitted major depression L Bartova, BM Meyer, K Diers, U Rabl, C Scharinger, A Popovic, G Pail, ... Journal of psychiatric research 64, 9-18, 2015 | 152 | 2015 |
| Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking HH Sitte, H Farhan, JA Javitch Molecular interventions 4 (1), 38, 2004 | 151 | 2004 |
| Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors CJ Loland, RI Desai, MF Zou, J Cao, P Grundt, K Gerstbrein, HH Sitte, ... Molecular pharmacology 73 (3), 813-823, 2008 | 148 | 2008 |
| Enhanced serotonin transporter function during depression in seasonal affective disorder M Willeit, HH Sitte, N Thierry, K Michalek, N Praschak-Rieder, P Zill, ... Neuropsychopharmacology 33 (7), 1503-1513, 2008 | 143 | 2008 |
| Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1 P Scholze, M Freissmuth, HH Sitte Journal of Biological Chemistry 277 (46), 43682-43690, 2002 | 140 | 2002 |
| PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein PJ Hamilton, AN Belovich, G Khelashvili, C Saunders, K Erreger, ... Nature chemical biology 10 (7), 582-589, 2014 | 136 | 2014 |
| Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action S Seidel, EA Singer, H Just, H Farhan, P Scholze, O Kudlacek, M Holy, ... Molecular pharmacology 67 (1), 140-151, 2005 | 133 | 2005 |
Michael FreissmuthMedical University of ViennaBestätigte E-Mail-Adresse bei meduniwien.ac.at
